Thurston Springer Miller Herd & Titak’s BeOne Medicines Ltd ONC Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.98K	Hold	21	–	–	﹤0.01%	950
2026 Q1	$6.24K	Hold	21	–	–	﹤0.01%	1018
2025 Q4	$6.38K	Buy	+21	New	+$6.87K	﹤0.01%	1059
2025 Q3	–	Sell	-21	Closed	-$5.08K	–	1419
2025 Q2	$5.08K	Hold	21	–	–	﹤0.01%	1278
2025 Q1	$5.71K	Buy	+21	New	+$4.91K	﹤0.01%	1246

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's ONC Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 21 shares worth $5.98K. The position accounts for ﹤0.01% of the portfolio, ranked #950.

Thurston Springer Miller Herd & Titak first reported a position in ONC in Q1 2025 and has held it in 5 quarters since. The position peaked at $6.38K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Thurston Springer Miller Herd & Titak held 21 shares of BeOne Medicines Ltd worth $5.98K as of Q2 2026.
Thurston Springer Miller Herd & Titak left its BeOne Medicines Ltd share count unchanged in Q2 2026.
BeOne Medicines Ltd made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #950 holding.
Thurston Springer Miller Herd & Titak first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 5 quarters since.
Thurston Springer Miller Herd & Titak's BeOne Medicines Ltd position peaked at $6.38K in Q4 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.